Cargando…
Gut microbiota-based pharmacokinetic-pharmacodynamic study and molecular mechanism of specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase
Specnuezhenide (SNZ) is among the main components of Fructus Ligustri Lucidi, which has anti-inflammation, anti-oxidation, and anti-tumor effect. The low bioavailability makes it difficult to explain the mechanism of pharmacological effect of SNZ. In this study, the role of the gut microbiota in the...
Autores principales: | Yu, Hang, Xu, Hui, Yang, Xinyu, Zhang, Zhengwei, Hu, Jiachun, Lu, Jinyue, Fu, Jie, Bu, Mengmeng, Zhang, Haojian, Zhai, Zhao, Wang, Jingyue, Jiang, Jiandong, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568112/ https://www.ncbi.nlm.nih.gov/pubmed/37842660 http://dx.doi.org/10.1016/j.jpha.2023.06.012 |
Ejemplares similares
-
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
por: Pan, Libin, et al.
Publicado: (2023) -
Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue
por: Wang, Jingyue, et al.
Publicado: (2023) -
Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis: Specnuezhenide suppresses diabetes-induced bone loss
por: Ye, Xiaoshuang, et al.
Publicado: (2022) -
Specnuezhenide Ameliorates Age-Related Hepatic Lipid Accumulation via Modulating Bile Acid Homeostasis and Gut Microbiota in D-Galactose-Induced Mice
por: Deng, Xuehui, et al.
Publicado: (2023) -
Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers
por: Wang, Xinwen, et al.
Publicado: (2021)